Tilray’s jump in a broad cannabis rally shows how shifting U.S. policy signals are jolting traders, today, Dec. 16, 2025.

Shares of U.S. and Canadian cannabis stocks continued their rally on Tuesday, after President Donald Trump a day earlier said he was “very strongly” weighing an executive order to reschedule the drug, ...

Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from ...

Few investors have more notoriety than Bill Ackman and Michael Burry, the latter portrayed in "The Big Short." ...

Canopy Growth led U.S. weed stocks higher in early European trading on Monday, adding to Friday's rally following reports ...

American Bitcoin stock is struggling on the charts.

President Donald Trump on Monday at the Oval Office spoke about the stock market and the impact that tariffs have had on the ...

President Donald Trump is expected to push for marijuana reclassification from Schedule I to Schedule III status, sending ...

An upcoming US Supreme Court ruling on the legality of the sweeping tariffs that President Donald Trump rolled out in April — ...

Trump is reportedly considering easy some restrictions on cannabis, and investors are piling into the sector on Friday.

The company and many of its peers saw dramatic lifts on the back of new Presidential remarks.

Green Thumb Industries stock is a Buy, with strong financials and major upside from potential cannabis rescheduling. Click ...